BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33322438)

  • 1. Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours.
    Gaurilcikas A; Gedgaudaite M; Cizauskas A; Atstupenaite V; Paskauskas S; Gaurilcikiene D; Birzietis T; Vaitkiene D; Nadisauskiene RJ
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322438
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
    He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
    J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions.
    Czekierdowski A; Stachowicz N; Smolen A; Łoziński T; Guzik P; Kluz T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
    Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
    Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating use of IOTA two-step strategy to classify adnexal masses identified in pregnancy: pilot study.
    Barcroft J; Pandrich M; Del Forno S; Cooper N; Linton-Reid K; Landolfo C; Timmerman D; Saso S; Bourne T
    Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38787921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
    Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
    J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study.
    Sayasneh A; Ferrara L; De Cock B; Saso S; Al-Memar M; Johnson S; Kaijser J; Carvalho J; Husicka R; Smith A; Stalder C; Blanco MC; Ettore G; Van Calster B; Timmerman D; Bourne T
    Br J Cancer; 2016 Aug; 115(5):542-8. PubMed ID: 27482647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Before surgery predictability of malignant ovarian tumors based on ADNEX model and its use in clinical practice].
    Joyeux E; Miras T; Masquin I; Duglet PE; Astruc K; Douvier S
    Gynecol Obstet Fertil; 2016 Oct; 44(10):557-564. PubMed ID: 27568408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.
    Pascual MA; Vancraeynest L; Timmerman S; Ceusters J; Ledger A; Graupera B; Rodriguez I; Valero B; Landolfo C; Testa AC; Bourne T; Timmerman D; Valentin L; Van Calster B; Froyman W
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic Assessment of Complex Ultrasound Morphology Adnexal Tumors in Pregnant Women with the Use of IOTA Simple Rules Risk and ADNEX Scoring Systems.
    Czekierdowski A; Stachowicz N; Smoleń A; Kluz T; Łoziński T; Miturski A; Kraczkowski J
    Diagnostics (Basel); 2021 Feb; 11(3):. PubMed ID: 33671023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
    Nohuz E; De Simone L; Chêne G
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
    Van Calster B; Valentin L; Froyman W; Landolfo C; Ceusters J; Testa AC; Wynants L; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Savelli L; Fischerová D; Czekierdowski A; Kaijser J; Coosemans A; Scambia G; Vergote I; Bourne T; Timmerman D
    BMJ; 2020 Jul; 370():m2614. PubMed ID: 32732303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.